# Dxn Pharmaceutical Sdn Bhd – FDA Inspection, Mar 6, 2026

Source: https://www.keypedia.com/records/fda_inspections/dxn-pharmaceutical-sdn-bhd/d9f90d30-b293-4f88-b9e7-6d6eada611dd
Source feed: FDA_Inspections

> FDA inspection 1305724 of Dxn Pharmaceutical Sdn Bhd, March 06, 2026. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 111. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1305724
- Company Name: Dxn Pharmaceutical Sdn Bhd
- Inspection Date: 2026-03-06
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Foodborne Biological Hazards
- Product Type: Foods & Cosmetics
- Center: Foods & Cosmetics
- Office Name: Office of Inspections and Investigations
- Citation Count: 1

## Related Documents

- [FDA Inspection 1007862 - 2017-03-16](https://www.keypedia.com/records/fda_inspections/dxn-pharmaceutical-sdn-bhd/eb34e37d-3790-4168-9617-a74791b39588)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/jackson-y-see/f0f4e260-8625-4dda-823d-55e4b4ff4ce7)

Company: https://www.keypedia.com/companies/dxn-pharmaceutical-sdn-bhd/c7a778e2-40f8-41a1-af4d-c632a3b04a1d

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8
